Фитонимическая лексика и ее отражение в языковой картине мира (На материале русского и болгарского языков)

Доклад посвящен изучению наименований лекарственного растения девясил высокий (болг. бял оман), относящегося к тематической группе "Лекарственные травянистые растения семейства Сложноцветные (Compositae)". В нем рассматривается происхождение наименований, определяются продуктивные способы образования, а также принципы номинации анализируемой растительной реалии в системе двух языков (русского и болгарского).This report dwells on the study of the names of the medicinal herbaceous plant cow parsnip (hogweed), related to the thematic group "Medicinal herbaceous plants of the Composite Family (Compositae)". It considers the origin of the nominations and determines the productive methods of formation, as well as the principles of nomination of the plant reality being analyzed in the system of the two languages (Russian and Bulgarian)

The impact of soil herbicides on the yield and quality of lavender (Lavandula angustifolia Mill.) essential oil

During the period 2014-2015, the herbicidal effect and the selectivity of isoxaflutole (Merlin 750 WG), oxadiargyl (Raft 400 SK), imazamox (Pulsar 40) and flumioxazine (Pledge 50 WP) were studied on lavender fields, Hemus and Jubilee varieties [1]. The present work focuses on the influence of low doses of the applied preparations on the yield and composition of the essential oil compared to the untreated control [2]. The results of a two-year study show that the treated lavender had a higher yield on average of 0.7-1.6 kg/decare (daa). The odoriferous ingredients were found to be: linalyl acetate (20.0-38.6%), linalool (20.6-46.2%), lavandulyl acetate (1.9-5.9%), 1,8-cineole (0.4-4.9%), and camphor (0.2-0.6%). The application of oxadiargyl resulted in greater changes in the composition of the Jubilee variety, whereas the Hemus variety was most influenced by isoxaflutole [3]

Phytochemical constituents of pressurized liquid extract from Ziziphus jujubа Mill. (Rhamnaceae) fruits and in vitro inhibitory activity on α-glucosidase, pancreatic α-amylase and lipase

The phytochemical composition of extract from Ziziphus jujubа Mill (Rhamnaceae) fruits obtained by pressurized liquid extraction (PLE) was investigated in the current study. The phytochemical analysis showed the presence of triterpenes, flavonoids and phenolic acids. The fruit extract had a total phenolic content of 21 ±2.01 mg gallic acid equivalents per g of extract. (mg GAE/g extract), and total flavonoid content 2.48 ± 0.24 mg catechin equivalents per g dried extract (mg CE/g extract). This study evaluated the in vitro antioxidant activity of jujube extract and its inhibitory effects on α-glucosidase and pancreatic α-amylase and lipase. The obtained results proved inhibition of α-glucosidase with 70.94% and inhibition of α-amylase with 56.08%. Enzyme kinetic studies indicated that the inhibitors in the extract have the most potent inhibition of lipase compared to the other two enzymes with inhibitory constant Ki of 0.074 mg/cm3 . These results suggest the possible application of extract from Z. jujubа fruits obtained by PLE in the management of metabolic disorders as a whole. These are the first studies on this plant species cultivated in Bulgari

Lipid Composition of Paulownia Seeds Grown in Bulgaria

DergiPark: 246128trakyafbdThe chemical composition of seeds from paulownia (Paulownia tomentosa) was investigated. The main components in the triacylglycerol fraction of the oil were linoleic (64.1%), oleic (21.2%) and palmitic acids (7.3%). ?-Tocopherol (approx. 100.0%) predominated in the tocopherol fraction, and in the sterol fraction – ß-sitosterol (79.2%), campesterol (10.3%) and stigmasterol (7.7%). In the seeds were established 10.6% protein, 9.5% cellulose and 38.2% hydrolysable carbohydrates

ICAO action plan on emissions reduction: Republic of Bulgaria

ICAO environmental action plans present States' measures to reduce emissions from international aviation. Action plans are a practical means for States to communicate to ICAO information on their activities to address CO2 emissions from international civil aviation. The level of detail of the information contained in an action plan demonstrates the effectiveness of actions and will ultimately enable ICAO to measure global progress towards meeting the goals set by Assembly Resolution A37-19

The Langmuir-Blodgett Technique as a Tool for Homeotropic Alignment of Fluorinated Liquid Crystals Mixed with Arachidic Acid

Some fluoro-substituted liquid crystals mixed with arachidic acid in monolayers formed at air-liquid (Langmuir films) and air-solid substrate (Langmuir-Blodgett films) interfaces were investigated. Molecular organization in Langmuir films was determined on the basis of the analysis of the shape of the surface pressure-mean molecular area isotherm and observations made by means of a Brewster angle microscope. It was found that in the compression process the liquid crystal molecules are pushed out towards the top of the first monolayer being in direct contact with the subphase. Langmuir films were transferred onto the quartz substrates at various surface pressures and mono- and multilayered Langmuir-Blodgett films were obtained. The films were characterized using electronic absorption measurements. The conditions for obtaining the homeotropic orientation of the liquid crystal molecules were determined

Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson's disease in midbrain dopaminergic neurons

Mutations in the SNCA gene cause autosomal dominant Parkinson’s disease (PD), with loss of dopaminergic neurons in the substantia nigra, and aggregation of α-synuclein. The sequence of molecular events that proceed from an SNCA mutation during development, to end-stage pathology is unknown. Utilising human-induced pluripotent stem cells (hiPSCs), we resolved the temporal sequence of SNCA-induced pathophysiological events in order to discover early, and likely causative, events. Our small molecule-based protocol generates highly enriched midbrain dopaminergic (mDA) neurons: molecular identity was confirmed using single-cell RNA sequencing and proteomics, and functional identity was established through dopamine synthesis, and measures of electrophysiological activity. At the earliest stage of differentiation, prior to maturation to mDA neurons, we demonstrate the formation of small β-sheet-rich oligomeric aggregates, in SNCA-mutant cultures. Aggregation persists and progresses, ultimately resulting in the accumulation of phosphorylated α-synuclein aggregates. Impaired intracellular calcium signalling, increased basal calcium, and impairments in mitochondrial calcium handling occurred early at day 34–41 post differentiation. Once midbrain identity fully developed, at day 48–62 post differentiation, SNCA-mutant neurons exhibited mitochondrial dysfunction, oxidative stress, lysosomal swelling and increased autophagy. Ultimately these multiple cellular stresses lead to abnormal excitability, altered neuronal activity, and cell death. Our differentiation paradigm generates an efficient model for studying disease mechanisms in PD and highlights that protein misfolding to generate intraneuronal oligomers is one of the earliest critical events driving disease in human neurons, rather than a late-stage hallmark of the disease

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Background: Canagliflozin reduces the risk of kidney failure in patients with type 2 diabetes mellitus and chronic kidney disease, but effects on specific cardiovascular outcomes are uncertain, as are effects in people without previous cardiovascular disease (primary prevention). Methods: In CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation), 4401 participants with type 2 diabetes mellitus and chronic kidney disease were randomly assigned to canagliflozin or placebo on a background of optimized standard of care. Results: Primary prevention participants (n=2181, 49.6%) were younger (61 versus 65 years), were more often female (37% versus 31%), and had shorter duration of diabetes mellitus (15 years versus 16 years) compared with secondary prevention participants (n=2220, 50.4%). Canagliflozin reduced the risk of major cardiovascular events overall (hazard ratio [HR], 0.80 [95% CI, 0.67-0.95]; P=0.01), with consistent reductions in both the primary (HR, 0.68 [95% CI, 0.49-0.94]) and secondary (HR, 0.85 [95% CI, 0.69-1.06]) prevention groups (P for interaction=0.25). Effects were also similar for the components of the composite including cardiovascular death (HR, 0.78 [95% CI, 0.61-1.00]), nonfatal myocardial infarction (HR, 0.81 [95% CI, 0.59-1.10]), and nonfatal stroke (HR, 0.80 [95% CI, 0.56-1.15]). The risk of the primary composite renal outcome and the composite of cardiovascular death or hospitalization for heart failure were also consistently reduced in both the primary and secondary prevention groups (P for interaction >0.5 for each outcome). Conclusions: Canagliflozin significantly reduced major cardiovascular events and kidney failure in patients with type 2 diabetes mellitus and chronic kidney disease, including in participants who did not have previous cardiovascular disease

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years